Peter G. Amanatides
Präsident bei Pharmalogika, Inc.
Profil
Peter G.
Amanatides has been Vice President of Quality Assurance & Quality Control for Noven Pharmaceuticals, Inc. since September 30, 2008.
Dr. Amanatides is a Director, Chairman of the Regulatory Compliance Committee, Vice President of Medical Affairs and a Member of the Compensation Committee for Generex Biotechnology Corp.
He has been President and Chief Operating Officer of Pharmalogika, Inc. since November 2004 and a Director and Vice President-Quality Organization of DSM Pharmaceuticals and DSM Biologics since April 2002.
From February 1999 to April 2002, Dr. Amanatides was Director of Quality Systems for Celera Genomics.
He received a BS degree in Biology from Regents College and an MS in Biotechnology and Molecular Biology from Hood College.
Aktive Positionen von Peter G. Amanatides
| Unternehmen | Position | Beginn |
|---|---|---|
| Pharmalogika, Inc. | Präsident | 01.11.2004 |
Noven Pharmaceuticals, Inc.
 Noven Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Noven Pharmaceuticals, Inc. operates as a pharmaceutical company with transdermal expertise. It specializes in the research and development, manufacture, marketing, and sale of prescription pharmaceutical products. The company was founded in 1987 and is headquartered in Miami, FL. | Corporate Officer/Principal | 30.09.2008 |
Ehemalige bekannte Positionen von Peter G. Amanatides
| Unternehmen | Position | Ende |
|---|---|---|
| GENEREX BIOTECHNOLOGY CORPORATION | Direktor/Vorstandsmitglied | 27.05.2008 |
Celera Group
 Celera Group Pharmaceuticals: MajorHealth Technology Celera Group provides molecular diagnostics using proprietary genomics and proteomics discovery platforms to identify and validate novel diagnostic markers and to develop diagnostic products based on these markers. These diagnostic products are used to predict disease risk and optimize therapy selection, monitoring and patient outcome. The company was founded in May, 1998 and is located in Rockville, MD | Corporate Officer/Principal | - |
DSM Pharmaceutical Products, Inc.
 DSM Pharmaceutical Products, Inc. Chemicals: Major DiversifiedProcess Industries Part of Thermo Fisher Scientific, Inc., DSM Pharmaceutical Products, Inc. is a science-based company that specializes in nutrition, health, and bioscience. The company is based in Parsippany, NJ. The company offers solutions for animal nutrition, human nutrition and care, food and beverage, and materials. DSM's companies cover a range of human and animal health and nutrition businesses. DSM's investor relations team provides key facts and figures, as well as shareholder information, to current and potential shareholders of DSM and to analysts. | Direktor/Vorstandsmitglied | 10.06.2009 |
Ausbildung von Peter G. Amanatides
| Hood College | Graduate Degree |
| Regent's Business School London | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Generex Biotechnology Corp.
 Generex Biotechnology Corp. Pharmaceuticals: MajorHealth Technology Generex Biotechnology Corp. is an integrated healthcare holding company with end-to-end solutions for patient centric care from rapid diagnosis through delivery of personalized therapies. It builds new kind of healthcare company, which provides support to physicians in an MSO network, and ongoing relationships with patients to improve the patient experience and access to optimal care. The company was founded by Rose C. Perri on September 4, 1997 and is headquartered in Miramar, FL. | Health Technology |
| Pharmalogika, Inc. | |
DSM Pharmaceutical Products, Inc.
DSM Pharmaceutical Products, Inc. Chemicals: Major DiversifiedProcess Industries Part of Thermo Fisher Scientific, Inc., DSM Pharmaceutical Products, Inc. is a science-based company that specializes in nutrition, health, and bioscience. The company is based in Parsippany, NJ. The company offers solutions for animal nutrition, human nutrition and care, food and beverage, and materials. DSM's companies cover a range of human and animal health and nutrition businesses. DSM's investor relations team provides key facts and figures, as well as shareholder information, to current and potential shareholders of DSM and to analysts. | Process Industries |
Noven Pharmaceuticals, Inc.
Noven Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Noven Pharmaceuticals, Inc. operates as a pharmaceutical company with transdermal expertise. It specializes in the research and development, manufacture, marketing, and sale of prescription pharmaceutical products. The company was founded in 1987 and is headquartered in Miami, FL. | Health Technology |
Celera Group
Celera Group Pharmaceuticals: MajorHealth Technology Celera Group provides molecular diagnostics using proprietary genomics and proteomics discovery platforms to identify and validate novel diagnostic markers and to develop diagnostic products based on these markers. These diagnostic products are used to predict disease risk and optimize therapy selection, monitoring and patient outcome. The company was founded in May, 1998 and is located in Rockville, MD | Health Technology |
